About Insight Genetics
Insight Genetics is a company based in Nashville (United States) founded in 2007 was acquired by OncoCyte in January 2020.. Insight Genetics has raised $3.05 million across 8 funding rounds from investors including OncoCyte and National Cancer Institute. The company has 3 employees as of December 31, 2019. Insight Genetics offers products and services including DetermaIO, VitaGraft Kidney, VitaGraft Liver, and GraftAssure. Insight Genetics operates in a competitive market with competitors including ChromaCode, Oncimmune, Biodesix, OncoCyte and InDex Pharmaceuticals, among others.
- Headquarter Nashville, United States
- Employees 3 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oncocyte Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Insight Genetics
Insight Genetics offers a comprehensive portfolio of products and services, including DetermaIO, VitaGraft Kidney, VitaGraft Liver, and GraftAssure. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assay for predicting immune therapy response in oncology.
Test for monitoring kidney transplant graft health.
Test for assessing liver transplant graft status.
Kit for detecting donor-derived cell-free DNA.
Funding Insights of Insight Genetics
Insight Genetics has successfully raised a total of $3.05M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $3.05 million completed in November 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $3.0M
-
First Round
First Round
(09 Nov 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2015 | Amount | Series A - Insight Genetics | Valuation |
investors |
|
| Jan, 2014 | Amount | Grant - Insight Genetics | Valuation |
investors |
|
| Aug, 2013 | Amount | Grant - Insight Genetics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Insight Genetics
Insight Genetics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include OncoCyte and National Cancer Institute. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cancer research is conducted and supported by the institute.
|
Founded Year | Domain | Location | |
|
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Insight Genetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Insight Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Insight Genetics Comparisons
Competitors of Insight Genetics
Insight Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaCode, Oncimmune, Biodesix, OncoCyte and InDex Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital molecular biology analytics are developed for disease management.
|
|
| domain | founded_year | HQ Location |
Diagnostics and risk assessment solutions for lung cancer are developed.
|
|
| domain | founded_year | HQ Location |
Cancer detection diagnostics assays are developed and offered.
|
|
| domain | founded_year | HQ Location |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Insight Genetics
When was Insight Genetics founded?
Insight Genetics was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Where is Insight Genetics located?
Insight Genetics is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Is Insight Genetics a funded company?
Insight Genetics is a funded company, having raised a total of $3.05M across 8 funding rounds to date. The company's 1st funding round was a Grant of $1.5M, raised on Nov 09, 2010.
How many employees does Insight Genetics have?
As of Dec 31, 2019, the latest employee count at Insight Genetics is 3.
What does Insight Genetics do?
Insight Genetics was founded in 2007 in Nashville, United States, within the molecular diagnostics sector. Precision cancer care is advanced through the discovery, development, and commercialization of companion diagnostics. Cancer testing services are provided to oncologists and pharmaceutical companies. A suite of molecular tests is offered, including the Insight ALK Screen and resistance assays for ALK-associated cancers, along with biomarkers, multiplex testing, next-generation sequencing, non-invasive methods, and resistance monitoring assays.
Who are the top competitors of Insight Genetics?
Insight Genetics's top competitors include ChromaCode, Biodesix and OncoCyte.
What products or services does Insight Genetics offer?
Insight Genetics offers DetermaIO, VitaGraft Kidney, VitaGraft Liver, and GraftAssure.
Who are Insight Genetics's investors?
Insight Genetics has 2 investors. Key investors include OncoCyte, and National Cancer Institute.